ABSTRACT OF THE WEEK

The Veterinary Clinics of North America. Food animal practice
Volume 37 | Issue 3 (November 2021)

Registered Medicinal Products for Use in Honey Bees in the United States and Canada.

Vet Clin North Am Food Anim Pract. November 2021;37(3):451-465.

Tracy S Farone¹

¹ Grove City College, 100 Campus Drive, Grove City, PA 16127, USA. Electronic address: tsfarone@gcc.edu.

Abstract

A 2017 US Food and Drug Administration mandate requiring veterinary oversight for medically important antibiotics used in agricultural animals, including honey bees (Apis mellifera L.) created a "new" animal requiring veterinary involvement. Many resources are available describing medical formulations of antibiotics and other drugs used in the treatment of various honey bee maladies. The goal of this article is to summarize this information in an up-to-date, practical way for the clinician. At the time of this writing, only 3 antibiotics are approved for use in honey bees and require veterinary prescriptions or veterinary feed directives.

Keywords

Antibiotic resistance; Honey bee antibiotics; Veterinary feed directive (VFD); Veterinary honey bee medications;

Article Tools:

Medline

Email to me

Archives Highlights:

Limb amputation for feline appendicular bone tumors results in excellent recovery outcomes and high owner satisfaction with a low incidence of complications.
Time to return to walking without support was < 3 days in 69.7% of cats and 3 to 7 days in 16.7%. Activity level changes were reported as no change in 75.8% of cats. There were no behavioral changes in 92.3% of cats. Quality of life following amputation was recorded as excellent in 82.4% of cats. Owner satisfaction was reported as very satisfied, moderately satisfied, or satisfied in 98.5% of cats.

National survey reveals elastic price sensitivity for select equine veterinary services.
Willingness-to-pay questions were presented with a payment card approach and addressed 3 common services: annual spring vaccinations, lameness examinations, and emergency colic surgeries. In a payment card approach, respondents choose from among preselected values. Respondents were asked to choose the maximum amount they would be willing to pay for each service.

Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small-Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma.
The median time to distant progression for all dogs was 265 days, with no significant difference between treatment groups. The median overall survival for all dogs was 270 days, and it was significantly different between amputated dogs (150 days) and those also receiving adjuvant chemotherapy (353 days). In our cohort, osteosarcoma in small breeds behaved as aggressive as in large breeds.

Efficacy, safety and interval from end of treatment to estrus in cats treated with an ultra-low dose megestrol acetate protocol for suppression of reproductive activity.
Twenty-eight queens were treated orally with 11.5 µg/kg/day of megestrol acetate (MA) for one to six months. MA suppressed reproductive function effectively in 27/28 queens. Transient mammary and uterine hyperplasia were detected in four (14 %) and three (11 %) queens, respectively, treated for more than four months, without associated clinical signs. Significant but reversible weight gain was observed in 85 % of the animals. The resumption of cyclicity occurred on average 6 weeks after the end of treatment but was influenced by the duration of treatment and seasonality.

Feline acute patient physiologic and laboratory evaluation scores and other prognostic factors in cats with first-time diabetic ketoacidosis.
Median BG was significantly higher in non-survivors (431 mg/dL) compared with survivors (343 mg/dL) and BG predicted mortality. For every 1 mg/dL increase in BG, the odds of death increased by 1.004.